[go: up one dir, main page]

NO984999D0 - Metoder for inhalasjon av t°rt pulver - Google Patents

Metoder for inhalasjon av t°rt pulver

Info

Publication number
NO984999D0
NO984999D0 NO984999A NO984999A NO984999D0 NO 984999 D0 NO984999 D0 NO 984999D0 NO 984999 A NO984999 A NO 984999A NO 984999 A NO984999 A NO 984999A NO 984999 D0 NO984999 D0 NO 984999D0
Authority
NO
Norway
Prior art keywords
dry powder
inhaler
inhalation
composition
microns
Prior art date
Application number
NO984999A
Other languages
English (en)
Norwegian (no)
Other versions
NO984999L (no
Inventor
Robert Schultz
Clyde Witham
Malcolm Hill
Original Assignee
Dura Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21777075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO984999(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dura Pharma Inc filed Critical Dura Pharma Inc
Publication of NO984999L publication Critical patent/NO984999L/no
Publication of NO984999D0 publication Critical patent/NO984999D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Flow Control (AREA)
NO984999A 1996-04-29 1998-10-27 Metoder for inhalasjon av t°rt pulver NO984999D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1642896P 1996-04-29 1996-04-29
PCT/US1997/006621 WO1997040819A1 (fr) 1996-04-29 1997-04-21 Methode d'inhalation de poudre seche

Publications (2)

Publication Number Publication Date
NO984999L NO984999L (no) 1998-10-27
NO984999D0 true NO984999D0 (no) 1998-10-27

Family

ID=21777075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984999A NO984999D0 (no) 1996-04-29 1998-10-27 Metoder for inhalasjon av t°rt pulver

Country Status (16)

Country Link
US (1) US6116237A (fr)
EP (1) EP0896525B1 (fr)
JP (2) JP2000510109A (fr)
AT (1) ATE247948T1 (fr)
AU (1) AU724503B2 (fr)
BR (1) BR9709748A (fr)
CA (1) CA2252814A1 (fr)
CZ (1) CZ343798A3 (fr)
DE (1) DE69724420T2 (fr)
DK (1) DK0896525T3 (fr)
ES (1) ES2205210T3 (fr)
HU (1) HUP9901575A3 (fr)
IL (1) IL126701A (fr)
NO (1) NO984999D0 (fr)
NZ (1) NZ332669A (fr)
WO (1) WO1997040819A1 (fr)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060069A (en) * 1991-05-20 2000-05-09 Dura Pharmaceuticals, Inc. Pulmonary delivery of pharmaceuticals
US6681767B1 (en) * 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
CA2112674C (fr) * 1991-07-02 2005-10-04 John S. Patton Methode et instrument pour la delivrance de medicaments en aerosol
CZ289029B6 (cs) 1994-09-21 2001-10-17 Inhale Therapeutic Systems Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu
NZ332669A (en) * 1996-04-29 1999-02-25 Dura Pharma Inc A dry power inhalation system which is flow rate independent
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
EP1066074A1 (fr) 1998-03-16 2001-01-10 Inhale Therapeutic Systems, Inc. Administration d'agents actifs sous forme d'aerosol
US6257233B1 (en) * 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
UA73924C2 (en) * 1998-10-09 2005-10-17 Nektar Therapeutics Device for delivering active agent formulation to lungs of human patient
JP2000217917A (ja) * 1999-01-27 2000-08-08 Unisia Jecs Corp 吸入式投薬器
WO2000065521A2 (fr) 1999-04-23 2000-11-02 Massachusetts Institute Of Technology Systeme et procede de notation de polymeres
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
US7305986B1 (en) * 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US6869789B2 (en) * 2000-03-08 2005-03-22 Massachusetts Institute Of Technology Heparinase III and uses thereof
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2382133C (fr) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Poudres a base de phospholipides permettant de distribuer un medicament
WO2002013897A2 (fr) 2000-08-14 2002-02-21 Advanced Inhalation Research, Inc. Inhalateur et procede correspondant
US7083937B2 (en) 2000-09-12 2006-08-01 Massachusetts Institute Of Technology Methods and products related to the analysis of polysaccarides
EP1328260A2 (fr) 2000-10-18 2003-07-23 Massachusetts Institute Of Technology Procedes et produits associes a l'administration pulmonaires de polysaccharides
US7225807B2 (en) * 2001-03-15 2007-06-05 Creare Incorporated Systems and methods for aerosol delivery of agents
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
CA2446904A1 (fr) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
WO2003024514A1 (fr) 2001-09-19 2003-03-27 Advent Pharmaceuticals Pty Ltd Inhaleur
WO2003053411A1 (fr) 2001-12-19 2003-07-03 Nektar Therapeutics Administration pulmonaire d'aminoglycosides
GB0201677D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
GB0217199D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
US6705316B2 (en) 2002-03-11 2004-03-16 Battelle Pulmonary Therapeutics, Inc. Pulmonary dosing system and method
AU2003220125B2 (en) 2002-03-20 2006-06-15 Mannkind Corporation Inhalation apparatus
DK1485154T3 (da) * 2002-03-20 2008-08-04 Alkermes Inc Pulverinhalationsindretning
US7185651B2 (en) 2002-06-18 2007-03-06 Nektar Therapeutics Flow regulator for aerosol drug delivery and methods
GB0217198D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
US20050251289A1 (en) * 2002-07-25 2005-11-10 Bonney Stanley G Medicament dispenser
WO2004011067A1 (fr) * 2002-07-25 2004-02-05 Glaxo Group Limited Distributeur de medicament
GB0217196D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicament dispenser
US7913688B2 (en) * 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
GB0308771D0 (en) * 2003-04-16 2003-05-21 Univ Loughborough Pulmonary drug delivery
CN100381083C (zh) 2003-04-29 2008-04-16 韩力 一种非可燃性电子喷雾香烟
EP1625336B9 (fr) 2003-05-21 2012-03-21 Alexza Pharmaceuticals, Inc. Utilisation d'une couche de combustible solide, procédé pour fabriquer une telle couche et unité de chauffage correspondante
GB0313604D0 (en) * 2003-06-12 2003-07-16 Britannia Pharmaceuticals Ltd Delivery device for powdered medicament
GB0317374D0 (en) * 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
US9345664B2 (en) * 2003-09-02 2016-05-24 Norton Healthcare Ltd Process for preparing a medicament
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
TW200533750A (en) 2004-02-19 2005-10-16 Coley Pharm Group Inc Immunostimulatory viral RNA oligonucleotides
IN2014DN01746A (fr) * 2004-04-02 2015-07-10 Government Of The Us Secretary Of The Dept Of Health And Human Services Ct S For Disease Control And
WO2005102429A1 (fr) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhalateur
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
GB0418278D0 (en) * 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
EP2314298B1 (fr) 2004-08-23 2015-05-27 MannKind Corporation Microparticules comprenant des sels de diketopiperazine permettant l'administration de médicaments
MX2007003046A (es) * 2004-09-16 2007-08-02 Giampiero Cossi Inhalador desechable para una sola dosis de medicamento en polvo.
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
GB0515584D0 (en) * 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
AU2006290870B2 (en) 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
EP1991678B2 (fr) 2006-02-15 2020-07-15 Rechtsanwalt Thomas Beck Compositions et procédés pour formulations à base d'oligonucléotides
DK1986679T3 (da) 2006-02-22 2017-11-20 Mannkind Corp Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
GB0622827D0 (en) * 2006-11-15 2006-12-27 Glaxo Group Ltd Sheet driver for use in a drug dispenser
WO2008112661A2 (fr) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Unité chauffante à utiliser dans un dispositif d'administration de médicament
WO2008156586A2 (fr) * 2007-06-12 2008-12-24 Alkermes, Inc. Perfectionnements à des dispositifs inhalateurs de poudre
CA2686217A1 (fr) * 2007-06-15 2008-12-18 Boehringer Ingelheim International Gmbh Inhalateur
EP2082762A1 (fr) * 2008-01-24 2009-07-29 Boehringer Ingelheim International Gmbh Inhalateur
AU2009228074B2 (en) * 2008-03-27 2015-01-22 Mannkind Corporation A dry powder inhalation system
CN103252007B (zh) 2008-06-13 2016-06-22 曼金德公司 干粉吸入器和用于药物输送的系统
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
JP5479465B2 (ja) 2008-06-20 2014-04-23 マンカインド コーポレイション 吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
AU2009296535B2 (en) 2008-09-26 2013-04-18 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members and related devices and methods
ES2570128T3 (es) 2008-09-26 2016-05-17 Oriel Therapeutics Inc Inhaladores con discos que tienen conductos de aire equipados con canales discretos de conductos de aire y discos y métodos relacionados
ES2561899T3 (es) * 2008-10-01 2016-03-01 Oriel Therapeutics, Inc. Inhaladores de polvo seco con mecanismos de perforación giratorios y dispositivos y métodos relacionados
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
KR101257597B1 (ko) 2009-02-23 2013-04-26 니뽄 다바코 산교 가부시키가이샤 비가열형 담배 향미 흡인기
EP2676695A3 (fr) * 2009-03-11 2017-03-01 MannKind Corporation Appareil, système et procédé de mesure de résistance d'un inhalateur
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
WO2011039646A2 (fr) 2009-09-30 2011-04-07 Inserm (Institut National De La Sante Et De La Recherche Medicale) Ciblage de particules d'administration de gène de papillomavirus
WO2011056889A1 (fr) 2009-11-03 2011-05-12 Mannkind Corporation Appareil et méthode de simulation d'efforts d'inhalation
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
CN105667994B (zh) 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
WO2013063160A1 (fr) 2011-10-24 2013-05-02 Mannkind Corporation Procédés et compositions pour traiter la douleur
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
KR101466616B1 (ko) * 2012-10-11 2014-11-28 한미약품 주식회사 건조분말 흡입장치
EP2911690A1 (fr) 2012-10-26 2015-09-02 MannKind Corporation Compositions et procédés de vaccin antigrippal inhalable
WO2014074797A1 (fr) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Poudres pulmonaires de densité ultra basse
US8545878B1 (en) 2012-11-09 2013-10-01 Civitas Therapeutics, Inc. Capsules containing high doses of levodopa for pulmonary use
US10034988B2 (en) * 2012-11-28 2018-07-31 Fontem Holdings I B.V. Methods and devices for compound delivery
EP2970149B1 (fr) 2013-03-15 2019-08-21 MannKind Corporation Compositions de dicétopipérazine microcristallines et procédés
CN105451716A (zh) 2013-07-18 2016-03-30 曼金德公司 热稳定性干粉药物组合物和方法
WO2015021064A1 (fr) 2013-08-05 2015-02-12 Mannkind Corporation Appareil d'insufflation et procédés
WO2015042412A1 (fr) 2013-09-20 2015-03-26 E-Nicotine Technology. Inc. Dispositifs et procédés de modification de dispositifs de distribution
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2016040575A1 (fr) 2014-09-10 2016-03-17 Fontem Holdings 1 B.V. Procédés et dispositifs de modulation d'écoulement d'air dans des dispositifs de distribution
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CA2965759C (fr) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Polypeptides en poudre presentant moins d'impuretes de disulfide comprenant des materiaux cationiques divalents
AU2016209328A1 (en) 2015-01-22 2017-08-17 Fontem Holdings 1 B.V. Electronic vaporization devices
IT201600093878A1 (it) 2016-09-19 2018-03-19 Hollycon Italy Pte Ltd S R L Inalatore monodose a perdere per medicinali in polvere
WO2018071427A1 (fr) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhalateur et ses méthodes d'utilisation
EP3746138B1 (fr) 2018-02-02 2025-12-10 Alexza Pharmaceuticals, Inc. Dispositif aérosol à condensation électrique

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB248400A (fr) * 1925-02-28 1926-11-18 Societe Francaise Des Films Herault
US3831606A (en) * 1971-02-19 1974-08-27 Alza Corp Auto inhaler
IT1220979B (it) * 1981-06-04 1990-06-21 Lofarma Farma Lab Capsule contenenti un allergene e procedimento per la loro preparazione
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
ES2087911T3 (es) * 1989-04-28 1996-08-01 Riker Laboratories Inc Dispositivo de inhalacion de polvo seco.
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
US5327883A (en) * 1991-05-20 1994-07-12 Dura Pharmaceuticals, Inc. Apparatus for aerosolizing powdered medicine and process and using
US5492112A (en) * 1991-05-20 1996-02-20 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5469843A (en) * 1991-11-12 1995-11-28 Minnesota Mining And Manufacturing Company Inhalation device
PL172758B1 (pl) * 1992-10-19 1997-11-28 Dura Pharma Inc Inhalator do proszków suchych PL PL PL PL PL PL PL
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
US5792057A (en) * 1993-05-21 1998-08-11 Aradigm Corporation Ventilation imaging using a fine particle aerosol generator
US5388574A (en) * 1993-07-29 1995-02-14 Ingebrethsen; Bradley J. Aerosol delivery article
JPH0753358A (ja) * 1993-08-17 1995-02-28 Teijin Ltd 吸入剤
US5524613A (en) * 1993-08-25 1996-06-11 Habley Medical Technology Corporation Controlled multi-pharmaceutical inhaler
US5522385A (en) * 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
US5645051A (en) * 1995-04-21 1997-07-08 Dura Pharmaceuticals, Inc. Unit dose dry powder inhaler
US5622166A (en) * 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
NZ332669A (en) * 1996-04-29 1999-02-25 Dura Pharma Inc A dry power inhalation system which is flow rate independent

Also Published As

Publication number Publication date
US6116237A (en) 2000-09-12
CA2252814A1 (fr) 1997-11-06
ATE247948T1 (de) 2003-09-15
JP2009148586A (ja) 2009-07-09
EP0896525B1 (fr) 2003-08-27
BR9709748A (pt) 2000-01-11
AU724503B2 (en) 2000-09-21
AU2737197A (en) 1997-11-19
WO1997040819A1 (fr) 1997-11-06
CZ343798A3 (cs) 1999-02-17
ES2205210T3 (es) 2004-05-01
EP0896525A1 (fr) 1999-02-17
EP0896525A4 (fr) 2001-01-10
NO984999L (no) 1998-10-27
DK0896525T3 (da) 2003-12-01
JP2000510109A (ja) 2000-08-08
HUP9901575A3 (en) 1999-11-29
NZ332669A (en) 1999-02-25
IL126701A (en) 2001-08-08
HUP9901575A2 (hu) 1999-08-30
IL126701A0 (en) 1999-08-17
DE69724420T2 (de) 2004-06-09
DE69724420D1 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
NO984999D0 (no) Metoder for inhalasjon av t°rt pulver
US11878114B2 (en) Nicotine powder inhaler
US12233204B2 (en) Nicotine powder delivery system
EP1137452B1 (fr) Dispositif d'ecartement pour inhalateur
JP2003503116A (ja) 吸入器
US12496415B2 (en) Nicotine powder inhaler
US20240139442A1 (en) Nicotine powder inhaler
HK40029937B (en) Nicotine powder delivery system
HK1261336B (en) Nicotine powder delivery system
HK1261336A1 (en) Nicotine powder delivery system
HK1228691A1 (en) Nicotine powder inhaler
HK1228691B (en) Nicotine powder inhaler
NZ329747A (en) Method of respiratory delivery of insulin as a dry powder
MXPA98008976A (en) Methods for inhalation of dusts se

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application